Transcriptomics

Dataset Information

0

Mutant IDH1 regulates the tumor-associated immune system in gliomas


ABSTRACT: Gliomas harboring mutations in isocitrate dehydrogenase 1/2 (IDH1/2) have the CpG island methylator phenotype (CIMP) and significantly longer patient survival time than wild-type IDH1/2 tumors. Although there are many factors underlying the differences in survival between these two tumor types, immune-related differences in cell content are potentially important contributors. In order to investigate the role of IDH mutations in immune response, we created a syngeneic pair mouse model for mutated IDH1 (mutIDH1) and wild-type IDH1 (wtIDH1) gliomas and demonstrated that muIDH1 mice showed many molecular and clinical similarities to muIDH1 human gliomas, including a 100-fold higher concentration of 2-hydroxygluratate (2-HG), longer survival time, and higher CpG methylation compared to wtIDH1. Also, we showed that IDH1 mutations caused downregulation of leukocyte chemotaxis, resulting in repression of the tumor-associated immune system. Given that significant infiltration of immune cells such as macrophages, microglia, monocytes, and neutrophils is linked to poor prognosis in many cancer types, these reduced immune infiltrates in muIDH1 glioma tumors may contribute in part to the differences in aggressiveness of the two glioma types.

ORGANISM(S): Mus musculus

PROVIDER: GSE96979 | GEO | 2017/05/21

SECONDARY ACCESSION(S): PRJNA380261

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-03-09 | PXD016697 | Pride
2020-03-09 | PXD016698 | Pride
2021-11-25 | PXD022752 | Pride
2021-05-26 | MTBLS2692 | MetaboLights
2012-02-16 | E-GEOD-30338 | biostudies-arrayexpress
2013-12-04 | E-GEOD-52942 | biostudies-arrayexpress
2010-04-26 | E-GEOD-16011 | biostudies-arrayexpress
2012-02-16 | E-GEOD-30336 | biostudies-arrayexpress
2010-12-20 | E-GEOD-20395 | biostudies-arrayexpress
2015-12-23 | E-GEOD-70991 | biostudies-arrayexpress